Envestnet Asset Management Inc Bio Techne Corp Transaction History

Envestnet Asset Management Inc

  • $302 Billion
  • Q3 2024

A detailed history of Envestnet Asset Management Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Envestnet Asset Management Inc holds 393,223 shares of TECH stock, worth $26.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
393,223
Previous 383,931 2.42%
Holding current value
$26.6 Million
Previous $27.5 Million 14.23%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$70.96 - $82.35 $659,360 - $765,196
9,292 Added 2.42%
393,223 $31.4 Million
Q2 2024

Aug 08, 2024
SELL
$62.12 - $84.15 $319,855 - $433,288
-5,149 Reduced 1.32%
383,931 $27.5 Million
Q1 2024

May 13, 2024
BUY
$65.98 - $77.09 $4.25 Million - $4.96 Million
64,382 Added 19.83%
389,080 $27.4 Million
Q4 2023

Feb 13, 2024
BUY
$52.83 - $78.22 $654,405 - $968,911
12,387 Added 3.97%
324,698 $25.1 Million
Q3 2023

Nov 13, 2023
BUY
$67.52 - $89.42 $5.91 Million - $7.82 Million
87,465 Added 38.9%
312,311 $21.3 Million
Q2 2023

Aug 04, 2023
BUY
$73.76 - $85.98 $941,988 - $1.1 Million
12,771 Added 6.02%
224,846 $18.4 Million
Q1 2023

May 11, 2023
BUY
$71.62 - $86.62 $57,510 - $69,555
803 Added 0.38%
212,075 $15.7 Million
Q4 2022

Feb 07, 2023
BUY
$80.67 - $352.29 $12.9 Million - $56.4 Million
160,181 Added 313.52%
211,272 $17.5 Million
Q3 2022

Nov 10, 2022
SELL
$282.54 - $391.85 $282 - $391
-1 Reduced -0.0%
51,091 $14.5 Million
Q2 2022

Aug 03, 2022
SELL
$322.67 - $449.65 $696,321 - $970,344
-2,158 Reduced 4.05%
51,092 $17.7 Million
Q1 2022

May 04, 2022
SELL
$353.85 - $487.79 $1.91 Million - $2.64 Million
-5,410 Reduced 9.22%
53,250 $23.1 Million
Q4 2021

Feb 04, 2022
BUY
$456.15 - $525.06 $376,779 - $433,699
826 Added 1.43%
58,660 $30.3 Million
Q3 2021

Oct 07, 2021
BUY
$444.87 - $538.88 $959,584 - $1.16 Million
2,157 Added 3.87%
57,834 $28 Million
Q2 2021

Aug 04, 2021
BUY
$387.35 - $450.26 $682,898 - $793,808
1,763 Added 3.27%
55,677 $25.1 Million
Q1 2021

May 04, 2021
BUY
$314.62 - $411.0 $2.91 Million - $3.8 Million
9,240 Added 20.68%
53,914 $20.6 Million
Q4 2020

Feb 02, 2021
BUY
$246.9 - $321.87 $1.52 Million - $1.98 Million
6,153 Added 15.97%
44,674 $14.2 Million
Q3 2020

Oct 09, 2020
BUY
$232.22 - $282.96 $1.73 Million - $2.11 Million
7,458 Added 24.01%
38,521 $9.54 Million
Q2 2020

Jul 08, 2020
BUY
$185.43 - $279.56 $429,085 - $646,901
2,314 Added 8.05%
31,063 $8.2 Million
Q1 2020

Apr 23, 2020
BUY
$161.17 - $221.51 $479,803 - $659,435
2,977 Added 11.55%
28,749 $5.45 Million
Q4 2019

Feb 11, 2020
BUY
$189.68 - $222.09 $328,905 - $385,104
1,734 Added 7.21%
25,772 $5.66 Million
Q3 2019

Oct 17, 2019
BUY
$183.56 - $216.72 $419,434 - $495,205
2,285 Added 10.5%
24,038 $4.7 Million
Q2 2019

Aug 02, 2019
BUY
$188.72 - $215.43 $197,401 - $225,339
1,046 Added 5.05%
21,753 $4.54 Million
Q1 2019

May 10, 2019
BUY
$136.09 - $200.44 $391,939 - $577,267
2,880 Added 16.16%
20,707 $4.11 Million
Q4 2018

Feb 13, 2019
BUY
$132.75 - $203.8 $2.37 Million - $3.63 Million
17,827 New
17,827 $2.58 Million
Q3 2018

Nov 14, 2018
SELL
$147.44 - $204.11 $1.44 Million - $2 Million
-9,796 Closed
0 $0
Q2 2018

Aug 10, 2018
BUY
$144.9 - $165.58 $26,082 - $29,804
180 Added 1.87%
9,796 $1.45 Million
Q1 2018

May 09, 2018
SELL
$131.46 - $151.04 $34,442 - $39,572
-262 Reduced 2.65%
9,616 $1.45 Million
Q4 2017

Feb 20, 2018
BUY
$121.17 - $134.75 $25,809 - $28,701
213 Added 2.2%
9,878 $1.28 Million
Q3 2017

Nov 13, 2017
SELL
$113.59 - $123.78 $212,526 - $231,592
-1,871 Reduced 16.22%
9,665 $1.17 Million
Q2 2017

Aug 14, 2017
BUY
N/A
11,536
11,536 $1.36 Million

Others Institutions Holding TECH

# of Institutions
603
Shares Held
151M
Call Options Held
195K
Put Options Held
53.2K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.65B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email